Idiopathic Constipation
📧 Sign up to get email alerts when something new happens for Idiopathic Constipation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-29FDA Approved: PRUCALOPRIDE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for PRUCALOPRIDE submitted by Viona Pharmaceuticals Inc.
-
FDA approval · 2026-01-16FDA Approved: PRUCALOPRIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA's original ANDA for prucalopride (generic) for the treatment of chronic idiopathic constipation.
-
FDA approval · 2025-08-07FDA Approved: PRUCALOPRIDE — Original Application (Viona Pharmaceuticals Inc)
FDA approved prucalopride via an original application filed by Viona Pharmaceuticals Inc for use in chronic constipation.
-
FDA approval · 2025-07-10FDA Approved: MOTEGRITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for MOTEGRITY (prucalopride) from Takeda Pharmaceuticals America, Inc., indicating an update to …
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for prucalopride. It is indicated for the treatment of chronic idiopathic constipatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for prucalopride, enabling a generic version for chronic idiopathic constipation.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for prucalopride (generic) for chronic idiopathic constipation.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (SpecGx LLC)
FDA approved the original application for prucalopride submitted by SpecGx LLC.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original abbreviated new drug application (ANDA) for prucalopride by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (SKG Pharma Inc.)
FDA approved a generic version of prucalopride (SKG Pharma Inc.) through an Original Application/ANDA submission (ANDA 218812). This generic…
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Sandoz Inc.)
FDA approved the original application for a generic version of prucalopride (PRUCALOPRIDE) by Sandoz Inc., for the treatment of chronic idio…
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Hikma Pharmaceuticals USA Inc)
FDA approved Hikma Pharmaceuticals USA Inc's prucalopride original application.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE SUCCINATE — Original Application (Somerset Therapeutics, LLC)
FDA approved Somerset Therapeutics, LLC's original application for prucalopride succinate as a generic version of prucalopride for adults wi…
-
FDA approval · 2025-01-02FDA Approved: LUBIPROSTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original generic application for lubiprostone to treat chronic idiopathic constipation, opioid-induced …
-
FDA approval · 2024-12-26FDA Approved: PRUCALOPRIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original Abbreviated New Drug Application for prucalopride, confirming a generic version of the prokinetic…
-
FDA approval · 2023-06-12FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Linzess (linaclotide) submitted by Allergan.
-
FDA approval · 2023-03-23FDA Approved: LUBIPROSTONE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for lubiprostone from Zydus Pharmaceuticals USA Inc., establishing a generic version of Lubiprostone. …
-
FDA approval · 2022-01-18FDA Approved: LUBIPROSTONE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's Lubiprostone generic under an original application (ANDA 209920). This marks approval of a generic version of lubipr…
-
FDA approval · 2021-04-12FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Linzess (linaclotide) from Allergan, Inc., to update/expand its label.
-
FDA approval · 2021-02-10FDA Approved: TRULANCE IMMEDIATE RELEASE — Supplemental Application (Salix Pharmaceuticals Inc.)
The FDA approved a supplemental application for Trulance Immediate Release (plecanatide) submitted by Salix Pharmaceuticals.
-
FDA approval · 2020-11-30FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for Lubiprostone submitted by Dr. Reddy's Laboratories, updating labeling under NDA 021908.
-
FDA approval · 2020-11-09FDA Approved: MOTEGRITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for MOTEGRITY (prucalopride) from Takeda Pharmaceuticals America, Inc., updating its labeling relate…
-
FDA approval · 2020-10-29FDA Approved: TRULANCE IMMEDIATE RELEASE — Supplemental Application (Salix Pharmaceuticals Inc.)
FDA approved a supplemental application to introduce an immediate-release formulation of Trulance (plecanatide) produced by Salix Pharmaceut…
-
FDA approval · 2020-09-22FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Linzess (linaclotide), submitted by Allergan, Inc.
-
FDA approval · 2018-12-14FDA Approved: MOTEGRITY — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved MOTEGRITY for chronic idiopathic constipation in adults in an original NDA from Takeda Pharmaceuticals America, Inc. (prucalopr…